Mark G. Currie, President at Cyclerion Therapeutics, Inc. (CYCN), bought 321,755 shares at $14.81 ($4.0M) on 2019-04-02, disclosed to the SEC on 2019-04-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 51,648 | $0 | 0.0% |
| 2 | $14.81 | 270,107 | $4.0M | 100.0% |
| Total | $12.43 avg | 321,755 | $4.0M | 100% |
| Filing → |
| IRWD | SELL | 2021-06-16 | $546K | — | Filing → |
| CYCN | SELL | 2020-12-30 | $121K | — | Filing → |
| IRWD | SELL | 2020-01-24 | $755K | — | Filing → |